(Q34998140)

5 August 2017

1 reference

title

Radiolabeled peptides in the diagnosis and therapy of oncological diseases (English)

1 reference

5 August 2017

Ronald E Weiner

1

1 reference

5 August 2017

Mathew L Thakur

series ordinal

2

1 reference

5 August 2017

publication date

1 November 2002

1 reference

Applied Radiation and Isotopes

5 August 2017

published in

1 reference

5 August 2017

volume

57

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

749-763

1 reference

Direct synthesis of [DOTA-DPhe1]-octreotide and [DOTA-DPhe1,Tyr3]-octreotide (SMT487): two conjugates for systemic delivery of radiotherapeutical nuclides to somatostatin receptor positive tumors in man

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

A chelating derivative of alpha-melanocyte stimulating hormone as a potential imaging agent for malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

The utility of a somatostatin-type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Somatostatin receptor scintigraphy using [111In-DTPA0]RC-160 in humans: a comparison with [111In-DTPA0]octreotide.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Radiolabeling of epidermal growth factor with 99mTc and in vivo localization following intracerebral injection into normal and glioma-bearing rats

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Imaging of renal cell cancer with radiolabelled octreotide.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Cell irradiation caused by diagnostic nuclear medicine procedures: dose heterogeneity and biological consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Autocrine and paracrine signaling through neuropeptide receptors in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Localisation of mesenchymal tumours by somatostatin receptor imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Somatostatin analogs in oncology: a look to the future

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Somatostatin receptor: scintigraphy and radionuclide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Somatostatin-receptor imaging of human malignancies: a new era in the localization, staging, and treatment of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

The value of octreotide scintigraphy in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Radiolabeled peptides and other ligands for receptors overexpressed in tumor cells for imaging neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Somatostatin receptor expression in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Yttrium-90-labelled somatostatin-analogue for cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Different chelators and different peptides together influence the in vitro and mouse in vivo properties of 99Tcm

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Phe1-octreotide in 194 carcinoid patients: Vienna University Experience, 1993 to 1998

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

A receptor-specific peptide for imaging infection and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

99mTc labeled VIP analog: evaluation for imaging colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

A new radioligand for the epidermal growth factor receptor: 111In labeled human epidermal growth factor derivatized with a bifunctional metal-chelating peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction?

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Uptake kinetics of the somatostatin receptor ligand [86Y]DOTA-DPhe1- Tyr3-octreotide ([86Y]SMT487) using positron emission tomography in non-human primates and calculation of radiation doses of the 90Y-labelled analogue.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Technetium-99m labeled epidermal growth factor-tumor imaging in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

OctreoTher: ongoing early clinical development of a somatostatin-receptor-targeted radionuclide antineoplastic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Octreotide scintigraphy for small cell lung carcinoma: past, present or future?

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Imaging tumors in humans with Tc-99m-VIP.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Somatostatin-receptor scintigraphy in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Somatostatin receptor imaging and therapy of pancreatic endocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2802%2900192-6

7 January 2021

10.1016/S0969-8043(02)00192-6

Identifiers

DOI

1 reference

5 August 2017

1 reference